Drug intelligence / Profile preview

evodiamine

Development stage
Unknown
Modality
Small Molecules
Administration
Oral, Intraperitoneal Injection, Subcutaneous Injection, Gavage, Fed (preclinical Models)
01

Overview

**Evodiamine** is a naturally occurring indole alkaloid and the primary bioactive component of the fruit Evodia rutaecarpa (also known as Euodia rutaecarpa), a traditional Chinese medicinal plant. It exhibits a range of pharmacological activities, including **antitumor, anti-inflammatory, cardioprotective, anti-atherosclerotic, anti-nociceptive, anti-gastric ulcer, and neuroprotective** effects. As a small molecule inhibitor, evodiamine is noted for its ability to suppress proliferation and migration of vascular smooth muscle cells (VSMCs), attenuate inflammation and oxidative stress, and modulate hormone secretion. Its antitumor effects have been demonstrated in multiple mouse cancer models, including colon, liver, lung, cervical, ovarian, pancreatic, breast, and lymphoma, with significant inhibition of tumor growth. The mechanism of action includes multi-target activity, with documented inhibition of the **PI3K/Akt signaling axis**, leading to reduced proliferation, migration, and inflammatory responses in vascular cells and cancer cells[1][3][4].

Other names
evodiamineisoevodiaminevodiaminecornishined-evodiaminedogwood baseevodiamine 98%evodiamine.p.eevodiamine std.
02

Targets

TRPV1 (Transient receptor potential cation channel subfamily V member 1)TOP1 (DNA Topoisomerase I)AHR (Aryl hydrocarbon receptor)

Beyond the preview

Go deeper on evodiamine.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on evodiamine.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call